-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HLMxGStBKa4wAEoOsL6S1Ghz0lcf5qe00dIZ69FwT6/Kfa6u1GcDeTPBTWJXawba TFjikW8UAIshW+zCpK8wwA== 0001399490-08-000016.txt : 20080213 0001399490-08-000016.hdr.sgml : 20080213 20080213130211 ACCESSION NUMBER: 0001399490-08-000016 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20071231 FILED AS OF DATE: 20080213 DATE AS OF CHANGE: 20080213 EFFECTIVENESS DATE: 20080213 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Redmile Group, LLC CENTRAL INDEX KEY: 0001425738 IRS NUMBER: 208592298 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-12776 FILM NUMBER: 08602987 BUSINESS ADDRESS: STREET 1: ONE FERRY BUILDING, SUITE 255 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 BUSINESS PHONE: 415-677-5341 MAIL ADDRESS: STREET 1: ONE FERRY BUILDING, SUITE 255 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 13F-HR 1 rm4q07.txt REDMILE 13F 4Q2007 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: December 31, 2007 Check here if Amendment [ ]; Amendment Number: This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Redmile Group, LLC Address: One Ferry Building, Suite 255 San Francisco, CA 94111 13F File Number: 28- The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Jeremy Green Title: Managing Member Phone: 415-677-5341 Signature, Place, and Date of Signing: Jeremy Green San Francisco, CA February 13, 2008 Report Type (Check only one.): [ X] 13F HOLDINGS REPORT. [ ] 13F NOTICE. [ ] 13F COMBINATION REPORT. FORM 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 0 Form13F Information Table Entry Total: 32 Form13F Information Table Value Total: $106,630 (thousands) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional managers with respect to which this report is filed, other than the manager filing this report. NONE FORM 13F INFORMATION TABLE VALUE SHARES/ SH/ PUT/ INVSTMT OTHER VOTING AUTHORITY NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DSCRETN MANAGERS SOLE SHARED NONE - ------------------------------ ---------------- --------- -------- -------- --- ---- ------- ------------ -------- -------- -------- AFFYMAX INC COM 00826A109 1948 87100 SH DEFINED 87100 AFFYMETRIX INC COM 00826T108 4667 201667 SH DEFINED 201667 ALLOS THERAPEUTICS INC COM 019777101 3829 608730 SH DEFINED 608730 ALTUS PHARMACEUTICALS INC COM 02216N105 1357 261976 SH DEFINED 261976 AMERICAN MED SYS HLDGS INC COM 02744M108 4937 341456 SH DEFINED 341456 AMYLIN PHARMACEUTICALS INC COM 032346108 3885 105000 SH DEFINED 105000 BIOMARIN PHARMACEUTICAL INC COM 09061G101 1345 38000 SH CALL DEFINED 38000 BIOMARIN PHARMACEUTICAL INC COM 09061G101 6938 196000 SH DEFINED 196000 CYPRESS BIOSCIENCES INC COM PAR $.02 232674507 1856 168265 SH DEFINED 168265 ENZO BIOCHEM INC COM 294100102 2447 192042 SH DEFINED 192042 EXPRESS SCRIPTS INC COM 302182100 1095 15000 SH DEFINED 15000 ILLUMINA INC COM 452327109 6282 106000 SH DEFINED 106000 ILLUMINA INC COM 452327109 4030 68000 SH CALL DEFINED 68000 IMCLONE SYS INC COM 45245W109 2128 49500 SH DEFINED 49500 LEMAITRE VASCULAR INC COM 525558201 1345 217009 SH DEFINED 217009 LIFECORE BIOMEDICAL INC COM 532187101 2059 142476 SH DEFINED 142476 MILLENNIUM PHARMACEUTICALS I COM 599902103 4014 267929 SH DEFINED 267929 MYLAN INC COM 628530107 3866 275000 SH DEFINED 275000 NEKTAR THERAPEUTICS COM 640268108 4800 715321 SH DEFINED 715321 NMT MED INC COM 629294109 1237 220070 SH DEFINED 220070 NXSTAGE MEDICAL INC COM 67072V103 5079 334809 SH DEFINED 334809 ORTHOFIX INTL N V COM N6748L102 4158 71720 SH DEFINED 71720 PHARMATHENE INC COM 71714G102 194 49100 SH DEFINED 49100 RESPIRONICS INC COM 761230101 5350 81700 SH DEFINED 81700 SAVIENT PHARMACEUTICALS INC COM 80517Q100 3872 168572 SH DEFINED 168572 SMITH & NEPHEW PLC SPDN ADR NEW 83175M205 1093 94900 SH DEFINED 94900 SOMAXON PHARMACEUTICALS INC COM 834453102 792 152100 SH DEFINED 152100 THORATEC CORP COM NEW 885175307 4457 245000 SH DEFINED 245000 TRUBION PHARMACEUTICALS INC COM 89778N102 201 20148 SH DEFINED 20148 WRIGHT MED GROUP INC COM 98235T107 9040 309909 SH DEFINED 309909 XENOPORT INC COM 98411C100 2362 42262 SH DEFINED 42262 ZIMMER HLDGS INC COM 98956P102 5967 90200 SH DEFINED 90200
-----END PRIVACY-ENHANCED MESSAGE-----